Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
about
Evaluation of dose reduction versus standard dosing for maintenance of remission in patients with spondyloarthritis and clinical remission with anti-TNF (REDES-TNF): study protocol for a randomized controlled trialCut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid ArthritisNovel approaches to biological therapy for psoriatic arthritis.Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients.Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis?REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients.Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysis.Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry.Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
P2860
Q35986462-99752DDE-2EF9-4CFB-9208-B328CAB3BC04Q36125286-B49A04A7-4886-42CA-B087-4A5F5A6EB7D8Q38634276-A0E54520-5861-46D0-8F5F-AD7A8BCE09D7Q38641431-B6DB642D-87F4-4B58-93AE-10C1897E0101Q39042940-9504DA67-7102-4AA0-A514-A6B8DDC03F71Q47097484-2441CF8B-B7DD-43D8-8302-3AA42E3B554EQ47191569-0D92B43E-9F36-402C-893F-37C077EDBD70Q48278236-CFA91E64-6521-4007-9435-C9A930E106C5Q48302611-A4A8B731-92E5-4699-BBC2-4EF0CAF4A58D
P2860
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@ast
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@en
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@nl
type
label
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@ast
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@en
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@nl
prefLabel
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@ast
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@en
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Spanish Rheumatology Society a ...... ylitis and psoriatic arthritis
@en
P2093
Alberto Morell-Baladrón
Alicia Herrero-Ambrosio
Benito Dorantes-Calderón
Blanca Hernández-Cruz
Carmen Martínez-Fernández
Emilio Martín-Mola
Francisco Javier de Toro-Santos
Isidoro González-Álvaro
Jesús Sanz-Sanz
José Andrés Román Ivorra
P2860
P304
P3181
P356
10.1093/RHEUMATOLOGY/KEU461
P407
P577
2014-12-19T00:00:00Z